SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-20-071855
Filing Date
2020-06-10
Accepted
2020-06-10 11:48:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM tm2021445d6_posam.htm POS AM 23706
  Complete submission text file 0001104659-20-071855.txt   24678
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-193726 | Film No.: 20954091
SIC: 2834 Pharmaceutical Preparations